Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Conspiracy theories aside, he was clearly fired. He raised $250 million over 4 years at an average cost basis of $12. When he left, the stick was between $6 and $7, so more than 40% erosion from the cost basis imvestors paid to recap the company. Four years is enough time for a CEO to begin to generate an ROI, but his strategy wasn't working and our large investors likely said enough is enough and pressured the BOD to make a change.